%0 Journal Article
%T Matrix metalloproteinase 2 (MMP-2) and its tissue inhibitor 2 (TIMP-2) in pancreatic cancer (PC)
%A Barbara Mroczko
%A Bogus£¿aw K£¿dra
%A Maciej Szmitkowski
%A Mariusz Gryko
%A Marta £¿ukaszewicz-Zaj£¿c
%A Sara P£¿czek
%J Archive of "Oncotarget".
%D 2019
%R 10.18632/oncotarget.26571
%X The incidence rate of pancreatic cancer (PC) is similar to mortality rate, thus searching specific tumor biomarkers of PC is sorely needed. Matrix metalloproteinase-2 (MMP-2) and the imbalance between MMP-2 and its tissue inhibitor (TIMP-2) play a critical role in tumor progression. We aim to assess the diagnostic and prognostic usefulness of serum MMP-2 and TIMP-2 as potential biomarkers in comparison to well-established tumor markers of PC (CA 19-9, carbohydrate antigen 19-9 and CEA, carcinoembryonic antigen)
%K biomarker
%K matrix metalloproteinases
%K pancreatic cancer
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349457/